🔥Trends in Cancer🆙 ✅Turning cold into hot: emerging strategies to fire up the tumor microenvironment 🎯Summary of the intrinsic, extrinsic, and systemic factors developing ‘cold’ tumors 👥Dr. Kaili Ma #LCSM OncoAlert #ICI cell.com/trends/cancer/…

Review: Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers brnw.ch/21wRhmB By Sarah C. Moser and Jos Jonkers from The Netherlands Cancer Institute Oncode Institute

Online Now: Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies dlvr.it/TJgGS3

Many immunomodulators, including TLR3 and other toll like receptors, have dual inhibitory and stimulatory functions They are double-edged sword! biomarkers.biomedcentral.com/articles/10.11…

Magnolia season in Oxford 🌸 📷 | Magdalen College, LinaFromOxford (Instagram) & Judy.Martin46 (Instagram)

Treatment Algorithm: This is the algorithm we’ve used during our discussion w/ Emil Lou, MD, PhD, FACP on #PancreaticCancer #OncTwitter #MedTwitter #gism CancerNetwork® OncoAlert

ADCs are rapidly moving to earlier line treatment for breast cancer. Will likely reach the (neo)adjuvant setting soon. Here’s a recap of key ADC phase 3 trials expected to shape practice in the next future:

Time to rethink cancer trials. 🧬 Precision oncology demands: -Early molecular profiling -Flexible evidence (Phase 1/2, real-world) -Tumor-agnostic approvals - Global equity New era, new rules. Nature Cancer OncoAlert Vivek Subbiah, MD G Curigliano MD PhD Razelle Kurzrock, MD ASCO ESMO - Eur. Oncology ECOG-ACRIN Cancer Research Group

🚨 ASCO #ASCO25 was absolutely incredible! 🧬✨ So many groundbreaking advances in oncology and exciting publications that are going to change patient care. 👉Sharing the key ones below The Lancet The Lancet Oncology Journal of Clinical Oncology JAMA JAMA Oncology Cancer Discovery - Also added the

Great paper from our ISLB Young Committee! A huge effort to keep sharing #LiquidBiopsy knowledge through reviews and editorials after major conferences worldwide. Follow us for more LB updates and insights! 🌍🧬 #ISLB #sciencecommunication

15/15 🎯 Call to action: Oncologists: Order NGS for ALL rare cancer patients Payers: Cover comprehensive profiling Patients/families: Advocate for testing Researchers: Continue building the evidence Every rare cancer patient deserves precision medicine! 🧬💙

🚨 Wow! Sunday morning brings an incredible trifecta - 2 NEJM papers + 1 The Lancet Haematology study dropping simultaneously with #EHA2025! 🩸📚 ⚡️ OncoAlert 1/3 Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia NEJM nejm.org/doi/full/10.10…

Absolutely insane amount of data in this resource from Chris Mason The Spatial Atlas of Human Anatomy (SAHA): A Multimodal Subcellular-Resolution Reference Across Human Organs biorxiv.org/content/10.110… Spatial data on 15million cells from 100 donors across multiple ages, mainly GI

Real-world HER2 testing across 65,000+ solid tumors after T-DXd approval. 🧬Highest HER2 3+ rates: Bladder 13.9% Uterine serous 13.6% GEJ 12.1% Breast 7.8% Gastric 6.6% 🧬0% in glioma, sarcoma, SCLC, GIST, thyroid, thymic... Routine HER2 IHC may not be needed for all tumors.

📢 Big News from ISLB! The Journal of Liquid Biopsy is Now Indexed in Scopus 🎉 We’re proud to share that the Journal of Liquid Biopsy — the official journal of the International Society of Liquid Biopsy (ISLB) — has been accepted for indexing on the Scopus platform! This major

Every cancer patient deserves a diagnosis Providing links. as requested. 2016 AMA journal paper: pubmed.ncbi.nlm.nih.gov/27078832/ 2023 ASCO journal paper pubmed.ncbi.nlm.nih.gov/36930859/ Vivek Subbiah, MD

We are proud to welcome and congratulate our new CoP Subcommittee leaders across Social Media, Research, Community/Rural, Global, AI and more. Your leadership will shape how we connect, advocate, and grow together. ASCO #ASCO_CoP #policy #advocacy

We are deeply saddened by the passing of Dr. Anita Borges, a doyen of pathology in India and an eminent pathologist of national and international repute. Her remarkable contributions, dedication, and zeal have left an indelible mark on the field of pathology, inspiring

#Liquidbiopsy on the road: truth or illusion? A 65-year-old with colon cancer gets a blood test 200 km away. The ctDNA report comes back negative Watch the full video here 👉 youtu.be/Z8quQBzIpPc?si… Please like , subscribe and share

How Oxford’s MSc in Precision Cancer Medicine Transformed My Professional Practice oncology.ox.ac.uk/blog/msc-pcm-s…. #Precisiononcology #pathology #departmentofoncology #universityofoxford #mscprecisioncancermedicine